AbbVie Seeks Approval of Risankizumab for Crohn Disease
The application is supported by data from two phase 3 induction studies (ADVANCE and MOTIVATE) and one phase 3 maintenance study (FORTIFY).
Gastrohepatic Disorders
Statins ID’d as Potential Therapy for Ulcerative Colitis
People with ulcerative colitis taking statins, regardless of their age, have nearly half the colectomy rates
Diluent Mix-Up Prompts Recall of Firvanq Kits
Firvanq is indicated for the treatment of Clostridium difficile-associated diarrhea and enterocolitis caused by Staphylococcus aureus (including methicillin-resistant strains).
Pharmacotherapies for Liver Fibrosis, NASH Resolution Ranked
Although NASH is a common cause of chronic liver disease, there is limited evidence surrounding its management.
Non-Antimicrobial Drugs Tied to Drug-Resistant Bacterial Infection
Proton pump inhibitors, beta-blockers, antimetabolites linked to infection with antibiotic-resistant bacteria
Ultra-Processed Food May Up Risk for Inflammatory Bowel Disease
Higher risk for developing IBD associated with higher intake of ultra-processed foods, such as soft drinks, salty snacks, processed meat
MPR Weekly Dose Podcast Episode 86
This week on the pod we speak about a fact sheet update for the Janssen COVID vaccine. Pfizer and BioNTech are working on a booster version of their vaccine. A supplement is found to contain a prescription ingredient. There’s a new treatment for patients with diabetic kidney disease. And two sunscreen brands are recalled due to the presence of benzene.
Some Hospitalized COVID-19 Patients Have Ongoing GI Symptoms
Malnutrition is the most persistent GI symptom up to six months following hospitalization
Add-On PPI Therapy May Improve Glycemic Control in Diabetes
However, treatment with proton pump inhibitors is not associated with risk for incident diabetes in the general population
Low FODMAP Diet and IBD: A Potential Option?
Current research indicates that short-term utilization of an LFD may help ameliorate some mild IBS symptoms associated with quiescent IBD, while further long term studies are still needed.
